Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

INTRODUCTION: End-stage kidney disease (ESKD) is a major public health problem affecting more than 2 million people worldwide. It is one of the most severe chronic non-communicable diseases. Haemodialysis (HD) is the most common therapeutic option but is also associated with a risk of cardiovascular...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Blankestijn, Peter J, Fischer, Kathrin I, Barth, Claudia, Cromm, Krister, Canaud, Bernard, Davenport, Andrew, Grobbee, Diederick E, Hegbrant, Jörgen, Roes, Kit C, Rose, Matthias, Strippoli, Giovanni FM, Vernooij, Robin WM, Woodward, Mark, de Wit, G Ardine, Bots, Michiel L
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Renal Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7044930/
https://ncbi.nlm.nih.gov/pubmed/32029487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-033228
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados